Nicole Kessa Wee

Dr. Nicole Kessa Wee


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
NWNicole Kessa Wee
Nicole Kessa Wee
KGKim-Ann Git
Kim-Ann Git
WLWen-Jeng Lee
Wen-Jeng Lee
GRGaurang Raval
Gaurang Raval
APAziz Pattokhov
Aziz Pattokhov
CTCher Heng Tan
Cher Heng Tan
Wee NK, et al. Korean J Radiol. 2024 Jul;25(7):603-612. https://doi.org/10.3348/kjr.2024.0419

18 June 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
NWNicole Kessa Wee
Nicole Kessa Wee
EFE.B. Fan
E.B. Fan
KLK.C.H. Lee
K.C.H. Lee
YCYew Woon Yew Chia
Yew Woon Yew Chia
TLT.C.C. Lim
T.C.C. Lim

17 September 2024 in Singapore Medical Journal
Verified
Journal Article
Closed access
NWNicole Kessa Wee
Nicole Kessa Wee
CTCher Heng Tan
Cher Heng Tan
ZCZhen Wei Choo
Zhen Wei Choo
CLChau Hung Lee
Chau Hung Lee
Introduction: Cancer rates for Prostate Imaging-Reporting and Data System (PI-RADS) 3 lesions are low. We aimed to determine the clinical and magnetic resonance imaging (MRI) parameters that can provide risk stratification for PI-RADS 3 transition zone (TZ) lesions to guide decision for biopsy, which can improve the cost-effectiveness of resource utilisation. Methods: The MRI scans of all patients who underwent MRI–ultrasound fusion targeted biopsy from 1 May 2016 to 31 December 2022 were retrospectively assessed by two board-certified abdominal radiologists. The following data were collected and analysed serum prostate-specific antigen, Prostatic Health Index (PHI), prostate volume, histological results, lesion size, location, diffusion-weighted imaging (DWI) parameter scores and overall PI-RADS score. Results: Two hundred and fourteen TZ lesions were included. Among 131 PI-RADS 3 lesions, those with marked restricted diffusion (DWI score ≥4), diameter ≥1 cm, prostrate-specific antigen density (PSAD) ≥0.11 and PHI ≥34 were more likely to contain clinically significant prostate cancer (csPCa; P = 0.04, 0.02, 0.049 and 0.05, respectively), with areas under the receiver operating characteristics curve of 0.9, 0.76, 0.84 and 0.80, respectively. Apical lesions were more likely to contain csPCa compared to midgland or basal lesions (P = 0.01). Conclusion: Clinical parameters (PSAD and PHI) and MRI features (lesion size, DWI score, lesion location) can be used to risk stratify PI-RADS 3 TZ lesions and guide decision for targeted biopsy.

1 September 2021
Verified
Journal Article
Closed access
NWNicole Kessa Wee
Nicole Kessa Wee
WCW S C Cheong
W S C Cheong
HLH M Low
H M Low

9 January 2024 in Acta Radiologica
Verified
Journal Article
Closed access
JCJingli Chong
Jingli Chong
NWNicole Kessa Wee
Nicole Kessa Wee
CTCher Heng Tan
Cher Heng Tan
HLHsien Min Low
Hsien Min Low
WCWei Da Chew
Wei Da Chew
CLChau Hung Lee
Chau Hung Lee
Background: Surveillance of pancreatic cysts are necessary due to risk of malignant transformation. However, reported progression rates to advanced neoplasia are variable and the high frequency of surveillance scans may pose a considerable burden on healthcare resources. Purpose: To validate the effectiveness of the Fukuoka Guidelines surveillance regime and determine if a longer surveillance interval can be established. Material and Methods: All magnetic resonance imaging (MRI) studies of the pancreas performed at our institution between January 2014 and December 2016 with at least one pancreatic cystic lesion and follow-up MRI or computed tomography (CT) over at least two years were reviewed for size, worrisome feature (WF), and high-risk stigmata (HRS) at diagnosis and follow-up imaging (up to year 6). Reference standards for advanced neoplasia were based on endoscopic ultrasound, fine needle aspiration cytology, or the presence of ≥2 WF or ≥1 HRS on imaging. Comparison of MRI features of progression and outcomes of diagnostic endpoints between lesions <20 mm and ≥20 mm was performed. Results: A total of 270 patients were included (201 cysts <20 mm, 69 cysts ≥20 mm). Compared with cysts <20 mm, cysts ≥20 mm were more likely to be associated with WF or HRS (40.6% vs. 12.4%; P ≤0.00001), demonstrate increase in size of ≥5 mm in two years (20.3% vs. 10.9%; P = 0.049), and develop advanced neoplasia (24.6% vs. 0.5%; P <0.00001). Conclusion: Pancreatic cysts <20 mm have a low risk of developing WF and HRS and surveillance interval may be lengthened.

1 January 2024 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
NWNicole Kessa Wee
Nicole Kessa Wee
KGKim-Ann Git
Kim-Ann Git
WLWen-Jeng Lee
Wen-Jeng Lee
GRGaurang Raval
Gaurang Raval
APAziz Pattokhov
Aziz Pattokhov
CTCher Heng Tan
Cher Heng Tan
Wee NK, et al. Korean J Radiol. 2024 Dec;25(12):1102-1103. https://doi.org/10.3348/kjr.2024.1073